Literature DB >> 7809096

Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors.

S Chouaib1, J Chehimi, L Bani, N Genetet, T Tursz, F Gay, G Trinchieri, F Mami-Chouaib.   

Abstract

The production of interleukin 12 (IL-12) following allogeneic stimulation and its involvement in the differentiation of allospecific cytotoxic T lymphocytes (CTLs) have been investigated. Supernatants of mixed lymphocyte cultures had detectable levels of IL-12 p40 which were completely abrogated after depletion of responder cells from monocytes. While addition to the culture of anti-IL-12 neutralizing antibodies partially inhibited the allogeneic proliferative response and the subsequent CTL activity, addition of IL-12 stimulated both responses, suggesting that endogenously produced IL-12 plays a role in the development of alloreactivity. Furthermore, using primary mixed cultures of lymphocytes from major histocompatibility complex-recombinant siblings identical for class II antigens and displaying class I disparity, we demonstrated that addition of recombinant IL-12 at the sensitizing phase of the primary mixed lymphocyte culture induced CTL activity. Under these stimulation conditions, addition of recombinant IL-12 also triggered cell proliferation, indicating that IL-12 provides both growth and differentiation signals. The mechanism underlying this process does not appear to require IL-2, since IL-12-mediated CTL generation was not abrogated by anti-IL-2 alpha-chain antibodies. IL-12 increased granzyme B and perforin mRNA accumulation in major histocompatibility complex class I-primed lymphocytes, suggesting that this cytokine activates these two genes in CTL precursors. We conclude that IL-12 can stimulate the generation of alloreactive CTLs. We suggest that IL-12 may play a role in helper cell-independent CTL generation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7809096      PMCID: PMC45498          DOI: 10.1073/pnas.91.26.12659

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells.

Authors:  M Aste-Amezaga; A D'Andrea; M Kubin; G Trinchieri
Journal:  Cell Immunol       Date:  1994-07       Impact factor: 4.868

Review 2.  Interleukin-12 and its role in the generation of TH1 cells.

Authors:  G Trinchieri
Journal:  Immunol Today       Date:  1993-07

3.  Modulation of perforin and granzyme messenger RNA expression in human natural killer cells.

Authors:  T W Salcedo; L Azzoni; S F Wolf; B Perussia
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

4.  Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.

Authors:  J Chehimi; N M Valiante; A D'Andrea; M Rengaraju; Z Rosado; M Kobayashi; B Perussia; S F Wolf; S E Starr; G Trinchieri
Journal:  Eur J Immunol       Date:  1993-08       Impact factor: 5.532

5.  Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes.

Authors:  P T Mehrotra; D Wu; J A Crim; H S Mostowski; J P Siegel
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

6.  Synergistic effects of interleukin 4 and interleukin 12 on NK cell proliferation.

Authors:  B Naume; M K Gately; B B Desai; A Sundan; T Espevik
Journal:  Cytokine       Date:  1993-01       Impact factor: 3.861

7.  Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.

Authors:  M Clerici; D R Lucey; J A Berzofsky; L A Pinto; T A Wynn; S P Blatt; M J Dolan; C W Hendrix; S F Wolf; G M Shearer
Journal:  Science       Date:  1993-12-10       Impact factor: 47.728

8.  Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity. Implications for the age-related decline in CTL.

Authors:  E T Bloom; J A Horvath
Journal:  J Immunol       Date:  1994-05-01       Impact factor: 5.422

9.  Antitumor and antimetastatic activity of interleukin 12 against murine tumors.

Authors:  M J Brunda; L Luistro; R R Warrier; R B Wright; B R Hubbard; M Murphy; S F Wolf; M K Gately
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

10.  Impaired interleukin 12 production in human immunodeficiency virus-infected patients.

Authors:  J Chehimi; S E Starr; I Frank; A D'Andrea; X Ma; R R MacGregor; J Sennelier; G Trinchieri
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  15 in total

1.  IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro.

Authors:  N Bhardwaj; R A Seder; A Reddy; M V Feldman
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Effects of alpha-galactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Valpha24+ Vbeta11+ T cells.

Authors:  H J Van Der Vliet; N Nishi; Y Koezuka; M A Peyrat; B M Von Blomberg; A J Van Den Eertwegh; H M Pinedo; G Giaccone; R J Scheper
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

3.  Recycled addition of CD4+ T cell-rich population for induction of human autologous cytotoxic T lymphocytes: A practically efficient method.

Authors:  K Saijo; H Tsurushima; K Tsuboi; T Nose; A Oki; T Ohno
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

4.  A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas.

Authors:  D F Dukers; R L ten Berge; J J Oudejans; K Pulford; D Hayes; J F Miseré; G J Ossenkoppele; L H Jaspars; R Willemze; C J Meijer
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

5.  Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.

Authors:  C Lapham; B Golding; J Inman; R Blackburn; J Manischewitz; P Highet; H Golding
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection.

Authors:  A P Galvão da Silva; I de Almeida Abrahamsohn
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

7.  Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection.

Authors:  F S Wang; L H Xing; M X Liu; C L Zhu; H G Liu; H F Wang; Z Y Lei
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

8.  Brucella abortus as a potential vaccine candidate: induction of interleukin-12 secretion and enhanced B7.1 and B7.2 and intercellular adhesion molecule 1 surface expression in elutriated human monocytes stimulated by heat-inactivated B. abortus.

Authors:  M Zaitseva; H Golding; J Manischewitz; D Webb; B Golding
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

9.  A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits.

Authors:  D H Presky; H Yang; L J Minetti; A O Chua; N Nabavi; C Y Wu; M K Gately; U Gubler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

10.  Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo.

Authors:  D P Sharma; A J Ramsay; D J Maguire; M S Rolph; I A Ramshaw
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.